Renaissance Technologies - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637139. A total of 10 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Renaissance Technologies ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$35
-14.6%
22,861
-2.1%
0.00%–
Q1 2023$41
-6.8%
23,361
+1.3%
0.00%–
Q4 2022$44
-99.9%
23,061
+12.2%
0.00%–
Q3 2022$43,000–20,561–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q2 2023.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders